The chemical class referred to as Dynlt1f Inhibitors encompasses a range of compounds specifically designed to inhibit the activity of the Dynlt1f protein. This protein, identified through extensive biochemical and molecular research, plays a crucial role in various cellular processes. The function of Dynlt1f is notably dependent on the cellular context and is influenced by a variety of environmental factors. Inhibitors targeting Dynlt1f are meticulously developed to bind selectively to this protein, thereby modulating its biological activity. The binding interaction is a key feature of these inhibitors, as it allows them to interfere directly with the biochemical pathways in which Dynlt1f is involved. By inhibiting the activity of Dynlt1f, these compounds aim to affect the associated cellular mechanisms, which are vital for the maintenance of cellular homeostasis and function.
The development of Dynlt1f Inhibitors is a complex and interdisciplinary process, involving the integration of molecular biology, chemistry, and structural biology. The initial phase of developing these inhibitors involves gaining a detailed understanding of the structure and function of the Dynlt1f protein. Advanced techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational molecular modeling are typically employed to elucidate the structural intricacies of Dynlt1f. This comprehensive understanding is essential for the rational design of inhibitors that are both effective and highly specific to their target. These inhibitors are often small molecules, designed to efficiently penetrate cellular membranes and establish a stable and potent interaction with Dynlt1f. The molecular design of these inhibitors is carefully optimized to ensure robust interactions with the target protein, typically involving the formation of hydrogen bonds, hydrophobic interactions, and van der Waals forces. The effectiveness of these inhibitors is rigorously tested through various biochemical assays, which are crucial for assessing their potency, specificity, and overall interaction profile. These assays provide important insights into the behavior of the inhibitors in controlled experimental conditions, paving the way for further investigations into their mechanism of action and interaction dynamics with Dynlt1f.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that can change chromatin structure and potentially decrease gene expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor that can cause hypomethylation of DNA and affect gene transcription. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Another DNA methyltransferase inhibitor that can lead to gene reactivation though hypomethylation. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A selective histone deacetylase inhibitor, altering chromatin and gene expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
HDAC inhibitor potentially leading to altered gene expression through changes in chromatin accessibility. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Histone deacetylase inhibitor that can induce hyperacetylation of histones, affecting gene expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Binds to GC-rich DNA sequences, potentially inhibiting transcription factors and affecting gene expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Blocks autophagic flux and can affect cellular regulatory processes and potentially gene expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Inhibitor of DNA topoisomerase I, leading to DNA damage and possible effects on gene expression. | ||||||
Aminopterin | 54-62-6 | sc-202461 | 50 mg | $102.00 | 1 | |
Folate analog that inhibits dihydrofolate reductase, leading to effects on DNA synthesis and gene expression. | ||||||